Sphera Funds Management Ltd.
101 holdingsFiling period: 2026-06-30Current AUM: $700.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Inds Ltd | 1.50M | $50.8M | $63.1M | 9.01% | +363.1K | 2026-06-30 |
| 2 | BIIB | Biogen Inc | 196.6K | $42.5M | $49.9M | 7.12% | +104.1K | 2026-06-30 |
| 3 | MLYS | Mineralys Therapeutics Inc | 1.47M | $39.7M | $26.7M | 3.82% | +130.0K | 2026-06-30 |
| 4 | — | Tower Semiconductor Ltd | 108.3K | $28.2M | $28.2M | 4.03% | -37,470 | 2026-06-30 |
| 5 | CYTK | Cytokinetics Inc | 320.0K | $27.3M | $20.2M | 2.88% | +20.9K | 2026-06-30 |
| 6 | XBI | Spdr Series Trust | 150.0K | $23.7M | $23.4M | 3.34% | -50,000 | 2026-06-30 |
| 7 | SNDX | Syndax Pharmaceuticals Inc | 1.01M | $22.2M | $13.8M | 1.98% | +290.0K | 2026-06-30 |
| 8 | RARE | Ultragenyx Pharmaceutical in | 588.5K | $19.6M | $9.5M | 1.35% | -220,839 | 2026-06-30 |
| 9 | BMRN | Biomarin Pharmaceutical Inc | 328.6K | $18.8M | $19.2M | 2.74% | +188.7K | 2026-06-30 |
| 10 | BBIO | Bridgebio Pharma Inc | 245.3K | $18.3M | $18.4M | 2.63% | +100 | 2026-06-30 |
| 11 | COGT | Cogent Biosciences Inc | 459.3K | $17.8M | $14.2M | 2.03% | +43.0K | 2026-06-30 |
| 12 | — | Nova Ltd | 25.2K | $13.7M | $13.7M | 1.95% | -28,197 | 2026-06-30 |
| 13 | INSM | Insmed Inc | 118.8K | $12.7M | $13.4M | 1.91% | -- | 2026-06-30 |
| 14 | MAZE | Maze Therapeutics Inc | 417.6K | $12.5M | $13.1M | 1.88% | +190.2K | 2026-06-30 |
| 15 | — | Astrazeneca PLC | 62.5K | $11.9M | $11.9M | 1.69% | -- | 2026-06-30 |
| 16 | SNY | Sanofi SA | 269.5K | $11.5M | $11.9M | 1.71% | -- | 2026-06-30 |
| 17 | HELP | Cybin Inc | 1.62M | $10.7M | $17.2M | 2.45% | +633.7K | 2026-06-30 |
| 18 | LLY | Eli Lilly & Co | 8.0K | $9.6M | $11.4M | 1.63% | -1,000 | 2026-06-30 |
| 19 | MDGL | Madrigal Pharmaceuticals Inc | 17.4K | $9.4M | $7.5M | 1.07% | +8.4K | 2026-06-30 |
| 20 | TRVI | Trevi Therapeutics Inc | 499.0K | $9.3M | $6.8M | 0.97% | -75,000 | 2026-06-30 |
| 21 | ORIC | Oric Pharmaceuticals Inc | 853.0K | $9.2M | $7.9M | 1.13% | +315.4K | 2026-06-30 |
| 22 | ACAD | Acadia Pharmaceuticals Inc | 356.5K | $9.0M | $7.3M | 1.05% | +100.3K | 2026-06-30 |
| 23 | CLDX | Celldex Therapeutics Inc New | 240.9K | $9.0M | $7.2M | 1.04% | -2,707 | 2026-06-30 |
| 24 | RYTM | Rhythm Pharmaceuticals Inc | 80.4K | $8.9M | $7.4M | 1.06% | -- | 2026-06-30 |
| 25 | LRCX | Lam Research Corp | 18.5K | $8.0M | $4.4M | 0.63% | -- | 2026-06-30 |
← Scroll →
Page 1 of 5